Astrazeneca (AZN) Return on Capital Employed [ROCE] (2009 - 2026)
Astrazeneca (AZN) reported Return on Capital Employed [ROCE] of 9.91% for Q3 2026, up 1.23 percentage points from 8.68% a year earlier but down 6.85 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2025, Astrazeneca posted Return on Capital Employed [ROCE] of 17.52%, up 4.13 percentage points from FY2024.
- Return on Capital Employed [ROCE] has a five-year change of +5.72 percentage points (FY2020 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at 13.39% in FY2024 (+1.39 pp), 12.00% in FY2023 and 1.66% in FY2021 (-10.14 pp).
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -0.72% in Q2 2022 and a high of 16.76% in Q2 2026.
- Year over year, Return on Capital Employed [ROCE] has now increased in each of the last 16 quarters, with an average year-over-year change of +1.87 percentage points over the last eight quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2023 (a gain of 11.17 percentage points); the low point was Q2 2022 (a drop of 12.79 percentage points).
- Per Business Quant data, the three quarters before Q3 2026 came in at 16.76% (Q2 2026), 9.76% (Q1 2026) and 16.43% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 11.32% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 17.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9.91% |
| Jun 30, 2026 | 16.76% |
| Mar 31, 2026 | 9.76% |
| Dec 31, 2025 | 16.43% |
| Sep 30, 2025 | 8.68% |
| Jun 30, 2025 | 14.94% |
| Mar 31, 2025 | 7.87% |
| Dec 31, 2024 | 13.06% |
| Sep 30, 2024 | 7.05% |
| Jun 30, 2024 | 12.11% |
| Mar 31, 2024 | 6.71% |
| Dec 31, 2023 | 12.04% |
| Sep 30, 2023 | 6.42% |
| Jun 30, 2023 | 10.41% |
| Mar 31, 2023 | 4.44% |
| Dec 31, 2022 | 5.39% |
| Sep 30, 2022 | 1.97% |
| Jun 30, 2022 | -0.72% |
| Mar 31, 2022 | 0.03% |
| Dec 31, 2021 | 1.26% |
API Access
Astrazeneca Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();